7th Global Symposium on Medical Ketogenic Diet Therapies 19th-22nd October 2021
Vitaflo sponsored symposium at the 7th Global Symposium on Medical Ketogenic Diet Therapies discussing the latest research for an alternative dietary management for drug resistant epilepsy. Professor Heales discusses some of the pre-clinical work for the mechanisms of decanoic acid (C10), providing an understanding to how the MCT diet works. This is followed by Professor Matthew Walker who discusses the clinical trial of K.Vita as an alternative dietary management for patients with drug resistant epilepsy (DRE).
You can read the K.Vita clinical paper on the Vitaflo UK site, please note this product will only be available in the UK in 2022.